A phase Ib/II clinical trial led by Mount Sinai researchers demonstrates successful outcomes in combining chemotherapy with immunotherapy for diffuse large B-cell lymphoma treatment.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.